| Aktienanzahl | 5,80 Mio. |
| Aktientyp | Stammaktie |
freiwilliges Delisting
https://ir.vyantbio.com/news-events/press-releases/detail/1320/vyant-bio-announces-voluntary-nasdaq-delisting-and-sec
Überprüfung strategischer Alternativen
https://ir.vyantbio.com/news-events/press-releases/detail/1318/vyant-bio-engages-lifesci-capital-to-explore-strategic
https://ir.vyantbio.com/news-events/press-releases/detail/1319/vyant-bio-commences-a-cash-preservation-plan-including-a